CHP Merger Reports Approval Of Extension Proposal

Author: Benzinga Newsdesk | November 24, 2021 05:01pm

CHP Merger Corp. (the "Company") (NASDAQ:CHPM) today announced that it held a special meeting of stockholders (the "Special Meeting") relating to the proposal (the "Extension Proposal") to amend the Company's amended and restated certificate of incorporation to extend the date by which the Company must complete its initial business combination with Integrity Implants Inc. d/b/a Accelus ("Accelus"), a U.S. based medical technology company focused on the spinal surgery market (the "Accelus Business Combination") from November 26, 2021 to May 26, 2022 (the "Extension"), which the stockholders voted to approve. The Extension Proposal is described in further detail in the Company's Definitive Proxy Statement on Schedule 14A (the "Proxy Statement"), filed with the U.S. Securities and Exchange Commission ("SEC") on October 29, 2021.

Posted In: CHPM